The findings indicate a significant role of the FGR-PI3K-AKT-SP1-DKK1 axis in CRC; however, further investigation is essential to understand the broader effects of targeting this pathway in various cancer types and among different patient populations. The gene discussed is AKT1; the disease is colorectal carcinoma.